新闻
2024-03-20
Anavex Life Sciences Initiates Placebo-Controlled U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in Schizophrenia
临床2期临床结果
2024-03-20
融资
2024-03-20
Int J Mol Sci:细胞外囊泡在系统性红斑狼疮治疗中的潜力
临床研究
2024-03-20
治疗MASH/NASH和2型糖尿病,创新药物达2期试验主要终点
突破性疗法基因疗法临床结果ASH会议
2024-03-20
特瑞思TRS005拟纳入突破性治疗品种
抗体药物偶联物突破性疗法IPO
2024-03-20
治疗胃癌,华昊中天「优替德隆口服胶囊」获FDA孤儿药资格!
孤儿药IPO疫苗
2024-03-20
CytomX Therapeutics Announces Milestone Achievement in PROBODY® T-Cell Engaging Bispecific (TCB) Collaboration with Astellas
引进/卖出
2024-03-20
抗体药物偶联物
2024-03-20
Aligos Therapeutics Announces the Initiation of the Phase 2a HERALD Study of ALG-055009 in MASH Subjects
临床1期临床2期
2024-03-20
Inventiva announces positive results from the Phase II, LEGEND, Proof-of-Concept study combining lanifibranor with empagliflozin in patients with MASH/NASH and T2D
临床结果快速通道突破性疗法